{"database": "press", "table": "releases", "rows": [["https://www.curtis.senate.gov/press-releases/curtis-rosen-introduce-bipartisan-bill-to-lower-costs-of-medications-medical-devices", "Curtis, Rosen Introduce Bipartisan Bill to Lower Costs of Medications, Medical Devices", "2025-12-04", "2025", "2025-12", "Republican", "Senate", "UT", "John R. Curtis", "C001114", "www.curtis.senate.gov", "curtis", "https://www.curtis.senate.gov/newsroom/press-releases", "scraper", "Washington, D.C. \u2013 Today, U.S. Senators Jacky Rosen (D-NV) and John Curtis (R-UT) introduced a bill to help reduce the cost of prescription drugs and medical devices, prevent drug shortages, boost domestic production, and create more jobs. Their bipartisan Expanding Access to Affordable Prescription Drugs and Medical Devices Act will create a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status, to support this critical industry and bolster nonprofit manufacturer production so more Americans can have access to lower cost medicine.\n\n\u201cAs Nevadans continue being squeezed by rising costs, I\u2019m working to lower costs any way I can,\u201d said Senator Rosen. \u201cWhether it\u2019s access to cancer-treating medication or insulin pumps, this bipartisan bill would help reduce costs by bringing medications and devices to the market at a reasonable price, while creating jobs right here at home. I will never stop fighting to ensure Nevadans can access the affordable medical care they depend on.\u201d\n\n\u201cSo much of what is lost in our conversation about healthcare is the true cost associated with medications and medical devices,\u201d said Senator Curtis. \u201cUtahns and their families look to Congress to help cut red tape and streamline innovation, and alongside Senator Rosen, this legislation will help secure the domestic supply chain and empower nonprofit manufacturers to improve our most vulnerable health care markets.\u201d\n\n\u201cWe appreciate the attention of Congress to the non-profit pharmaceutical model,\u201d said Ned McCoy, President and CEO of Civica Rx. \u201cThis helps advance our mission to address drug shortages and ensure fair drug prices for consumers.\u201d\n\n\u201cNonprofit pharmaceutical companies are tackling important public health needs and drug supply challenges\u2014such as drug shortages and high prices\u2014that aren\u2019t being effectively addressed by traditional companies,\u201d said Dan Liljenquist, Chief Strategy Officer at Intermountain Health. \u201cThis legislation will help additional companies deliver on their important nonprofit missions.\u201d", 1, "2026-03-30T01:40:41Z", "2026-04-06T20:09:11Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://www.curtis.senate.gov/press-releases/curtis-rosen-introduce-bipartisan-bill-to-lower-costs-of-medications-medical-devices"], "units": {}, "query_ms": 1.742808846756816, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}